MS
Insider
Mark Sabag
See "Remarks"Mark Sabag (See "Remarks") filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $6.2M of TEVA (216,892 sh across 2 lots, as filed), executed Dec 9 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$13.1M
shares × price, as filed
Last traded
May 1
Filed May 4
Median ADV $196.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $22.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
TEVARecent filings
TEVASALE
Teva Pharmaceutical Industries Limited
View filing →
$5.0M144,180 sh × $34.99
Exec May 1
Filed May 4 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $1.9M
62,102 sh × $30.14
Exec Mar 17
Filed Mar 19 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $6.2M
216,892 sh across 2 lots
Exec Dec 9 2025
Filed Dec 11 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $6.1M
337,915 sh × $18.04
Exec May 8 2025
Filed May 12 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $2.9M
177,626 sh × $16.25
Exec Feb 12 2025
Filed Feb 14 2025 · 5:30 PM ET